Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 EUR | +4.27% | +3.83% | +9.42% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 44.63K 47.72K 3.98M | Sales 2022 | 12.23K 13.08K 1.09M | Capitalization | 5.91M 6.32M 527M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.28M -357M | Net income 2022 | - 0 0 | EV / Sales 2021 | 429 x |
Net Debt 2021 | 121K 130K 10.81M | Net cash position 2022 | 1.84M 1.97M 164M | EV / Sales 2022 | 333 x |
P/E ratio 2021 |
-4.68
x | P/E ratio 2022 |
-7.12
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.86% |
1 day | +4.27% | ||
1 week | +3.83% | ||
Current month | +30.48% | ||
1 month | +61.59% | ||
3 months | -2.40% | ||
6 months | -58.64% | ||
Current year | +9.42% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.488 | +4.27% | 1,027 |
25/24/25 | 0.468 | 0.00% | 239 |
24/24/24 | 0.468 | -0.43% | 239 |
23/24/23 | 0.47 | +0.86% | 239 |
22/24/22 | 0.466 | -0.85% | 750 |
Delayed Quote Xetra, April 26, 2024 at 09:06 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+9.42% | 2.68M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- T5O Stock